A Non-severe Coronavirus Disease 2019 Patient With Persistently High Interleukin-6 Level

• Ngā kaituhi matua: Nurfarah Lydia Hambali (Author), Malehah Mohd Noh (Author), Shahleni Paramasivam (Author), Tock Hing Chua (Author), Firdaus Hayati (Author), Alvin Oliver Payus (Author), Tze Yuan Tee (Author), Khairul Taufiq Rosli (Author), Mohammad Faruq Abd Rachman Isnadi (Author), Benny O. Manin (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Interleukin 6 (IL-6) is one of the markers of immune system activation indicating existent infection and inflammation. We present here a case of a 55-year-old male COVID-19 patient with an unusual high level of interleukin 6 (IL-6). Further investigation revealed he had hepatocellular carcinoma (HCC...